Michel Habib

Michel is a seasoned Venture Capitalist and senior executive investing in MedTech & Biotech, an expert in value building throughout the whole spectrum of tech companies development, with a track record of successful exits of over 1.5 $Bn.

Currently serves as Managing General Partner of ALIVE Israel HealthTech Fund. Serves on the BOD of Innovalve and Beyeonics.

Former advisor to CBG Ltd, a multi Billion family office based in London.

Former CEO of Hadasit Bio-Holdings (HDST), serves on the BOD of Enlivex (ENLV), Kahr Medical, Minovia, Omnix, Eximore, Xenia Ventures, and VLX Incubator, served on the BOD of Meditate (acquired by Olympus), Chairman of Kahr and on the BOD of Cellcure (acquired by Biotime (LCTX)).